Lista de obras -

Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group

scientific article published on 15 February 2019

Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials

artículo científico publicado en 2018

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations ⬇️

artículo científico publicado en 2016

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.

artículo científico publicado en 2018

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

artículo científico publicado en 2018

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis

scientific article published on 01 November 2019

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

artículo científico publicado en 2014

Fatigue in rheumatoid arthritis: time for a conceptual model

artículo científico publicado en 2011

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

artículo científico publicado en 2015

Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations

artículo científico publicado en 2019

Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT.

artículo científico publicado en 2015

Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia

artículo científico publicado en 2023

Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic Pain

artículo científico publicado en 2015

Ms. A.M. Taylor, et al reply ⬇️

artículo científico publicado en 2016

Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing

artículo científico publicado en 2019

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018

artículo científico publicado en 2019

Practice Advisory on the Appropriate Use of NSAIDs in Primary Care

artículo científico publicado en 2020

Transforming clinical trials in rheumatology: towards patient-centric precision medicine

artículo científico publicado en 2020

Translating IL-6 biology into effective treatments

scientific article published on 23 April 2020

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

artículo científico publicado en 2014

Updating the OMERACT filter: implications for patient-reported outcomes

artículo científico

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity

artículo científico publicado en 2014

Lista de obras de

Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group

Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations ⬇️

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

Fatigue in rheumatoid arthritis: time for a conceptual model

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations

Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT.

Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia

Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic Pain

Ms. A.M. Taylor, et al reply ⬇️

Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018

Practice Advisory on the Appropriate Use of NSAIDs in Primary Care

Transforming clinical trials in rheumatology: towards patient-centric precision medicine

Translating IL-6 biology into effective treatments

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

Updating the OMERACT filter: implications for patient-reported outcomes

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity